These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2544809)

  • 1. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus.
    Khatchikian D; Orlich M; Rott R
    Nature; 1989 Jul; 340(6229):156-7. PubMed ID: 2544809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus.
    Orlich M; Gottwald H; Rott R
    Virology; 1994 Oct; 204(1):462-5. PubMed ID: 8091680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of an influenza virus A/turkey/Oregon/71 HA insertion variant by the subtilisin-like endoprotease furin.
    Morsy J; Garten W; Rott R
    Virology; 1994 Aug; 202(2):988-91. PubMed ID: 8030261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis, cloning, and determination of the primary structure of a full-length DNA copy of the gene for influenza A/Alma-Ata/1417/84 virus (H1N1-serovariant HSW1N1) hemagglutinin].
    Beklemishev AB; Nazarova LM; Filimonov NG; Blinov VM; Grinev AA; Chuvakova ZK; Kim EV; Mukazhanova GN
    Mol Gen Mikrobiol Virusol; 1993; (1):24-7. PubMed ID: 8510679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the cleavage activation of the influenza virus hemagglutinin by site-specific mutagenesis.
    Garten W; Vey M; Ohuchi R; Ohuchi M; Klenk HD
    Behring Inst Mitt; 1991 Jul; (89):12-22. PubMed ID: 1930091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico.
    Horimoto T; Rivera E; Pearson J; Senne D; Krauss S; Kawaoka Y; Webster RG
    Virology; 1995 Oct; 213(1):223-30. PubMed ID: 7483266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of the hemagglutinin gene of H9N2 Korean avian influenza viruses and assessment of the pathogenic potential of isolate MS96.
    Lee CW; Song CS; Lee YJ; Mo IP; Garcia M; Suarez DL; Kim SJ
    Avian Dis; 2000; 44(3):527-35. PubMed ID: 11006999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host.
    Smirnov YA; Lipatov AS; Van Beek R; Gitelman AK; Osterhaus AD; Claas EC
    Acta Virol; 2000 Feb; 44(1):1-8. PubMed ID: 10989685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a foreign epitope by porcine reproductive and respiratory syndrome virus.
    Groot Bramel-Verheije MH; Rottier PJ; Meulenberg JJ
    Virology; 2000 Dec; 278(2):380-9. PubMed ID: 11118361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different hemagglutinin cleavage site variants of H7N7 in an influenza outbreak in chickens in Leipzig, Germany.
    Röhm C; Süss J; Pohle V; Webster RG
    Virology; 1996 Apr; 218(1):253-7. PubMed ID: 8615031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenic determinant of influenza virus.
    Rott R
    Vet Microbiol; 1992 Nov; 33(1-4):303-10. PubMed ID: 1481363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
    Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
    Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics.
    Lee CW; Lee YJ; Senne DA; Suarez DL
    Virology; 2006 Sep; 353(2):388-95. PubMed ID: 16828833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
    Kobasa D; Takada A; Shinya K; Hatta M; Halfmann P; Theriault S; Suzuki H; Nishimura H; Mitamura K; Sugaya N; Usui T; Murata T; Maeda Y; Watanabe S; Suresh M; Suzuki T; Suzuki Y; Feldmann H; Kawaoka Y
    Nature; 2004 Oct; 431(7009):703-7. PubMed ID: 15470432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia.
    Guo YJ; Krauss S; Senne DA; Mo IP; Lo KS; Xiong XP; Norwood M; Shortridge KF; Webster RG; Guan Y
    Virology; 2000 Feb; 267(2):279-88. PubMed ID: 10662623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
    Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
    J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
    Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants for infectivity and pathogenicity of influenza viruses.
    Rott R
    Philos Trans R Soc Lond B Biol Sci; 1980 Feb; 288(1029):393-9. PubMed ID: 6103557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.